Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PRESS: Getting Struck Twice: Acquisitions And Spinouts In Biotech <i>(Forbes)</i>

PRESS: Getting Struck Twice: Acquisitions And Spinouts In Biotech (Forbes)

Related Content

OCC Rescinds Recovery Planning Standards and Guidelines

SEC’s Compliance and Disclosure Interpretations Now Known as Corporation Finance Interpretations (CFIs)

Kansas City Fed Approves Limited Purpose Account for Kraken Financial

SEC Adopts Rules to Implement Section 16 Filing Requirements for Insiders of FPIs; Separately Adopts Conditional Exemptions to Requirements for Insiders of FPIs Incorporated in Select Countries

New York Proposes New Regulations for Buy-Now-Pay-Later Loans

SEC Chairman Atkins Speaks on Steps SEC is Taking to Encourage IPOs

The Competition for AI’s Scarcest Resource

FinCEN Issues Exceptive Relief Order on Beneficial Ownership Verification Requirements

Goodwin is Number One for M&A in Q1 2026

Goodwin Advises Document Crunch in Acquisition by Trimble

Goodwin Expands Technology Group With Addition of Veteran M&A Partner Michael Russell in San Francisco

Goodwin Advises Centessa on Definitive Agreement to Be Acquired by Lilly for Up to $7.8 Billion

Legal 500 EMEA 2026 Recognizes Goodwin for Excellence in France, Germany, and Luxembourg

Goodwin Advised Synnovation Therapeutics in Acquisition of Pikavation by Novartis for $2 Billion Upfront and Up To $1 Billion in Milestones

Chambers Europe 2026 Recognizes Goodwin Across Belgium, Luxembourg, and the United Kingdom

Private Placements and Hybrid Securities Offerings 2026

Life Sciences

Mergers & Acquisitions

Technology M&A